Riskpilot← Back to searchSign inGet full accessTOTAL PHARMA AS
ASActiveOrg 920250335Bryggerikaien 24, 4014 StavangerEconomic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
NOK 0
+100% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | +100% |
| Total assets | NOK 0 | — |
| Equity | NOK -22K | +0% |
| Employees | 0 | — |
Legal name
TOTAL PHARMA AS
Org number
920250335
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
16. januar 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Handel med farmasøytiske legemidler og medisinsk-kirurgiske sykehusartikler, samt aktiv deltagelse i nærliggende handelsforetagende.
Address
Bryggerikaien 24, 4014 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −13 | −7 | −6 | −7 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −13 | −7 | −6 | −7 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −13 | −7 | −6 | −7 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −7 | −6 | −7 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 | 1 | 0 | 0 | 0 |
| Equity | −2 | −9 | −15 | −22 | −22 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 10 | 15 | 22 | 22 |
| Total debt | 5 | 10 | 15 | 22 | 22 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
-2165100.0%
This company
38.2%
Market median
-5667901% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Deputy Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Total As
TOTAL PHARMA AS Board members of TOTAL PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Saeed Behar | Board of Directors | 0 companies |
| Mudhafar Jebur Ali | Chairman | 0 companies |
| Ali Kamil Abed | Board of Directors | 0 companies |
| Moustafa Kamil | Board of Directors | 0 companies |
| Ahmed Kamil Jamel Abed | Board of Directors | 0 companies |
| David Kamil | Deputy Chairman | 0 companies |